SLC37A4‐CDG: Second patient
Abstract Recently, a disorder caused by the heterozygous de novo c.1267C>T (p.R423*) substitution in SLC37A4 has been described. This causes mislocalization of the glucose‐6‐phosphate transporter to the Golgi leading to a congenital disorder of glycosylation type II (SLC37A4‐CDG). Only one patien...
Main Authors: | Matthew P. Wilson, Dulce Quelhas, Elisa Leão‐Teles, Luisa Sturiale, Daisy Rymen, Liesbeth Keldermans, Valérie Race, Erika Souche, Esmeralda Rodrigues, Teresa Campos, Emile Van Schaftingen, François Foulquier, Domenico Garozzo, Gert Matthijs, Jaak Jaeken |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-03-01
|
Series: | JIMD Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/jmd2.12195 |
Similar Items
-
SLC35A2-CDG: Novel variant and review
by: Dulce Quelhas, et al.
Published: (2021-03-01) -
SLC37A4-CDG: Mislocalization of the glucose-6-phosphate transporter to the Golgi causes a new congenital disorder of glycosylation
by: Thorsten Marquardt, et al.
Published: (2020-12-01) -
Four New Cases of SLC35A2-CDG With Novel Mutations and Clinical Features
by: Kuerbanjiang Abuduxikuer, et al.
Published: (2021-05-01) -
Clinical, molecular and glycophenotype insights in SLC39A8-CDG
by: Eleonora Bonaventura, et al.
Published: (2021-07-01) -
ALG11-CDG: Three novel mutations and further characterization of the phenotype
by: L. Regal, et al.
Published: (2015-03-01)